Peter N. Reikes - 04 Jun 2026 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Reporting relationship: Director
Issuer ticker: IONS
Reported as of: 04 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jun 2026, 16:59:38 UTC
Prior SEC filing: 19 Oct 2021
Source filing: View source filing
Reporting owner signature: By: Patrick R. O'Neil, attorney-in-fact For: Peter N. Reikes

Key filing fact

Peter N. Reikes filed Form 4 for IONIS PHARMACEUTICALS INC (IONS) on 08 Jun 2026.

Key facts

This page summarizes Peter N. Reikes's Form 4 filing for IONIS PHARMACEUTICALS INC (IONS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Jun 2026, 16:59.

Change

Previous filing in this sequence was filed on 19 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001753652 Primary reporting owner

Reikes Peter N

Relationship: Director
Address: 2855 GAZELLE COURT, CARLSBAD
Signature: By: Patrick R. O'Neil, attorney-in-fact For: Peter N. Reikes
Signature date: 05 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IONS transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value
Shares: +10,753
Change %
Price: $0.000000^*
Shares after: 10,753
Date: 04 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,753
Exercise price: $75.13
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Grant of 06/04/2026 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended & Restated 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in three equal annual installments, the first installment vesting on 06/04/2027. The option shall be fully vested and exercisable on 06/04/2029. The stock option was exercisable as to 0 shares on 06/04/2026.